Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - TOTAL CURRENT ASSETS
Total Current Assets SMMT - Summit Therapeutics Inc.
190 M
LAST VALUE
39.63%
2 YEAR CAGR
25.35%
5 YEAR CAGR
43.55%
10 YEAR CAGR